| scholarly article | Q13442814 |
| P50 | author | Thomas G Christensen | Q54877799 |
| P2093 | author name string | R Breuer | |
| G Izbicki | |||
| M W Conner | |||
| M J Segel | |||
| P2860 | cites work | Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification | Q34066372 |
| Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. | Q35765029 | ||
| Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. | Q35885653 | ||
| Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis | Q35905547 | ||
| Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases | Q36273592 | ||
| Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures | Q36347298 | ||
| Bleomycin-induced interstitial pneumonia in dogs | Q36492758 | ||
| Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied | Q39482869 | ||
| Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse | Q39576515 | ||
| Diffuse Pulmonary Interstitial Disease; An Immunohistologic Study | Q39882238 | ||
| The ultrastructure of human fibrosing alveolitis | Q40335198 | ||
| Lymphokine stimulation of collagen accumulation | Q40528990 | ||
| Circulating immune complexes in patients with cryptogenic fibrosing alveolitis | Q40728432 | ||
| The effect of suramin on bleomycin-induced lung injury | Q40838941 | ||
| Immunofluorescent patterns in the idiopathic interstitial pneumonias | Q40891368 | ||
| Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury. | Q43565541 | ||
| Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin | Q44774978 | ||
| Lung lymphocytes in bleomycin-induced pulmonary disease | Q45047357 | ||
| Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J mice. | Q54344668 | ||
| High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. | Q54396897 | ||
| Idiopathic Pulmonary Fibrosis | Q56804123 | ||
| Separation and characterization of lymphocytes from rat lung parenchyma. | Q64990730 | ||
| Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury | Q67531268 | ||
| Class II antigens of the major histocompatibility complex are increased in lungs of bleomycin-treated rats | Q67678531 | ||
| Study of immune complexes in bronchoalveolar lavage fluids | Q68042912 | ||
| A study of human interstitial lung diseases with special reference to immune complexes and hyaline membrane | Q68856799 | ||
| Intratracheal versus intravenous administration of bleomycin in mice: acute effects | Q68967096 | ||
| Immunological involvement in pulmonary fibrosis induced by peplomycin | Q69381155 | ||
| Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules | Q71006522 | ||
| The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury | Q71189434 | ||
| The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis | Q71459210 | ||
| Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis | Q71790672 | ||
| Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism | Q72648816 | ||
| The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation | Q72697175 | ||
| A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats at various times during the development of bleomycin-induced pulmonary fibrosis | Q72724287 | ||
| Effect of immunomodulators on bleomycin-induced lung injury | Q73071738 | ||
| The effect of enoxaparin on bleomycin-induced lung injury in mice | Q73113013 | ||
| Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis | Q73934059 | ||
| Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis | Q74164487 | ||
| P433 | issue | 3 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 111-119 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | International Journal of Experimental Pathology | Q15750807 |
| P1476 | title | Time course of bleomycin-induced lung fibrosis | |
| P478 | volume | 83 |
| Q54958024 | A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model. |
| Q36846759 | A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury |
| Q37664164 | A mouse model of chronic idiopathic pulmonary fibrosis |
| Q98196660 | A novel protective role of sacubitril/valsartan in cyclophosphamide induced lung injury in rats: impact of miRNA-150-3p on NF-κB/MAPK signaling trajectories |
| Q46795700 | A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep. |
| Q34116805 | A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model |
| Q36438280 | A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair |
| Q51058083 | A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? |
| Q36980497 | A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis |
| Q48208455 | AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis |
| Q34625430 | Acid Sphingomyelinase Deficiency Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis in Mice |
| Q96131300 | Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity |
| Q42499227 | Acute lung injury augments hypoxic ventilatory response in the absence of systemic hypoxemia. |
| Q34718159 | Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology |
| Q35325160 | Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. |
| Q53763737 | Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9. |
| Q39457197 | Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. |
| Q54941566 | Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. |
| Q39329326 | Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium. |
| Q90741842 | Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice |
| Q37041521 | Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π. |
| Q42875432 | Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model |
| Q35957896 | Bleomycin-Treated Chimeric Thy1-Deficient Mice with Thy1-Deficient Myofibroblasts and Thy-Positive Lymphocytes Resolve Inflammation without Affecting the Fibrotic Response |
| Q59329044 | Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis |
| Q51452644 | Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis. |
| Q37266352 | Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats |
| Q35994486 | Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia |
| Q41661771 | Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis |
| Q41861701 | Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis. |
| Q27003892 | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis |
| Q37672706 | Cellular senescence mediates fibrotic pulmonary disease |
| Q36628472 | Comparison between conventional and "clinical" assessment of experimental lung fibrosis. |
| Q35755955 | Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis |
| Q36853612 | Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis |
| Q36138255 | Deletion of mTORC1 Activity in CD4+ T Cells Is Associated with Lung Fibrosis and Increased γδ T Cells |
| Q44873764 | Detection of an Integrin-Binding Mechanoswitch within Fibronectin during Tissue Formation and Fibrosis |
| Q36713583 | Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. |
| Q41303019 | Dynamic expression of transformating growth factor-β1 and caveolin-1 in the lung of Bleomycin-induced interstitial lung disease |
| Q39229980 | EP4 Receptor-Associated Protein in Macrophages Protects against Bleomycin-Induced Pulmonary Inflammation in Mice. |
| Q46726026 | Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. |
| Q54365521 | Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. |
| Q46836355 | Effects of erdosteine on bleomycin-induced lung fibrosis in rats |
| Q47952164 | Effects of nintedanib on the microvascular architecture in a lung fibrosis model |
| Q33895012 | Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice |
| Q48111085 | Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats |
| Q64907689 | Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis. |
| Q35623595 | Evaluation of lung injury in rats and mice |
| Q36300021 | Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis |
| Q41159764 | Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. |
| Q36467021 | Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis |
| Q43258294 | Extracorporeal photopheresis in a rat model of pulmonary fibrosis |
| Q52720045 | FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts. |
| Q37088303 | Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion |
| Q34388069 | Fra-1/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo |
| Q51547972 | Fractional ventilation mapping using inert fluorinated gas MRI in rat models of inflammation and fibrosis. |
| Q46378553 | Genetic susceptibility to toxicologic lung responses among inbred mouse strains following exposure to carbon nanotubes and profiling of underlying gene networks |
| Q36205965 | Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo |
| Q50351279 | Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice. |
| Q44393156 | Human amnion epithelial cells repair established lung injury |
| Q37257183 | Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. |
| Q92246784 | Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice |
| Q64066403 | IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury |
| Q36897675 | Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis |
| Q97420386 | Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin |
| Q50711133 | Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG). |
| Q33783426 | Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis |
| Q37257106 | In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization. |
| Q36780178 | Inflammation-associated remodelling and fibrosis in the lung - a process and an end point |
| Q28391009 | Inhalation of carbon black nanoparticles aggravates pulmonary inflammation in mice |
| Q50132040 | Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis |
| Q52930728 | Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β. |
| Q37289134 | Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings |
| Q39835492 | Integrin-linked kinase (ILK) in pulmonary fibrosis |
| Q33946587 | Integrins, myofibroblasts, and organ fibrosis |
| Q35916866 | Longitudinal in vivo microcomputed tomography of mouse lungs: No evidence for radiotoxicity |
| Q39642363 | Luteolin Ameliorates Experimental Lung Fibrosis Both in Vivo and in Vitro: Implications for Therapy of Lung Fibrosis |
| Q51768434 | MR imaging, targeting and characterization of pulmonary fibrosis using intra-tracheal administration of gadolinium-based nanoparticles. |
| Q60950058 | Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis |
| Q39802680 | Mast cells: a pivotal role in pulmonary fibrosis |
| Q35358557 | Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis |
| Q47261430 | Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing. |
| Q92265900 | Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis |
| Q38610456 | Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades |
| Q27308781 | Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice |
| Q35083612 | Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. |
| Q47606264 | Murine Gammaherpesvirus 68: A Small Animal Model for Gammaherpesvirus-Associated Diseases |
| Q40426338 | NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns |
| Q36501195 | Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes |
| Q89621763 | Noninvasive Monitoring of Bleomycin-induced Lung Injury in Rats Using Pulmonary Function Test |
| Q30540289 | Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). |
| Q44070994 | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. |
| Q35624348 | Overexpression of Telomerase Protects Human and Murine Lung Epithelial Cells from Fas- and Bleomycin-Induced Apoptosis via FLIP Upregulation |
| Q39034108 | Pentoxifylline Inhibits Epidural Fibrosis in Post-Laminectomy Rats. |
| Q37056483 | Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis |
| Q85207281 | Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells |
| Q90236822 | Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment |
| Q37731036 | Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol |
| Q35695573 | Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis |
| Q41459860 | Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis |
| Q46406304 | Protection against bleomycin-induced lung injury by IL-18 in mice |
| Q95725479 | Pyunkang-hwan (Pyunkang-Tang) ameliorates air pollutant-induced inflammatory hypersecretion of airway mucus and bleomycin- induced pulmonary fibrosis in rats |
| Q35983620 | Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance |
| Q41429523 | Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury |
| Q50957855 | Role of insulin like growth factor axis in the bleomycin induced lung injury in rats. |
| Q51628601 | Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts. |
| Q41635155 | Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts. |
| Q85167809 | STY39, a Novel Alpha-Melanocyte-Stimulating Hormone Analogue, Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice |
| Q27303153 | Soluble TNF mediates the transition from pulmonary inflammation to fibrosis |
| Q33917582 | Static and dynamic mechanics of the murine lung after intratracheal bleomycin |
| Q35647590 | Stem cells in the lung. |
| Q35728036 | Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis |
| Q48522005 | Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations |
| Q36667164 | The Chinese Herbal Medicine Formula mKG Suppresses Pulmonary Fibrosis of Mice Induced by Bleomycin |
| Q38606433 | The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats |
| Q36970923 | The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? |
| Q43227519 | The effects of hemodilution on acute inflammatory responses in a bleomycin-induced lung injury model |
| Q38266276 | The extracellular matrix modulates the hallmarks of cancer |
| Q38290539 | The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis |
| Q50069018 | The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis |
| Q89187517 | The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis |
| Q37042139 | Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis |
| Q97568944 | Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis |
| Q34186283 | Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis |
| Q37089910 | Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor. |
| Q99555954 | Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs |
| Q46387801 | Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis |
| Q28389223 | Understanding cellular mechanisms underlying airway epithelial repair: selecting the most appropriate animal models |
| Q38088363 | Update on models of pulmonary fibrosis therapy for preclinical drug research. |
| Q35972946 | Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice |
| Q34480454 | Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis |
Search more.